Tag Archive | "acquisition"

Endo International acquires Par Pharmaceutical

Tags: , ,


Endo International and Par Pharmaceutical Holdings have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. Read the full story

Mayne acquires Doryx rights from Actavis

Tags: , , , ,


Actavis has entered into an agreement with Mayne Pharma, under which it will divest the U.S. rights to the Doryx Read the full story

Acquisition agreement for Shanxi Powerdone

Tags: , ,


Harbin Gloria Pharma pay $380 million to acquire an 85% stake in Shanxi Powerdone, which makes chemical drugs and compound preparations. Read the full story

Pfizer acquires Redvax, gains promising CMV vaccine candidate

Tags: , , ,


Pfizer has acquired a controlling interest in Redvax Read the full story

Otsuka acquires Avanir Pharma for $3.5 billion

Tags: , , ,


Otsuka Pharmaceutical announced an agreement with Avanir Pharmaceuticals, in which Otsuka America, acquires Avanir for USD 3.5 billion in an all-cash tender offer Read the full story

BioMarin acquires Prosensa for up to $840 million

Tags: , ,


BioMarin Pharmaceutical and Prosensa Holding have entered into a definitive agreement in which BioMarin will offer to purchase all of the outstanding ordinary shares of Prosensa for $17.75 per share, for a total up front consideration of approximately $680 million Read the full story

Zoetis acquires Abbott animal health assets

Tags: , , , ,


Zoetis announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million Read the full story

Actavis agrees to acquire Allergan in $66 billion deal

Tags: , , , ,


Actavis and Allergan have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock Read the full story

Baring Asia acquires Bushu Pharmaceuticals

Tags: ,


Baring Private Equity Asia said on Monday it has agreed to buy Japanese drugmaker Bushu Pharmaceuticals, valued at 77.3 billion yen ($668 million), from Tokio Marine Capital Read the full story

M&A news: Perrigo buys Omega Pharma for $4.5 billion

Tags: , ,


In today's m&a news, Perrigo Company announced today that it will acquire Belgium-based Omega Pharma for $4.5 billion. Read the full story